TBR-760 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses TBR-760 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses TBR-760 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid SyndromeTerminatedPhase 2IpsenNCT01018953Written as BIM 23A760How we know
- TBR-760 in Adult Patients With Non-Functioning Pituitary AdenomasStatus unknownPhase 2Tiburio TherapeuticsNCT04335357Written as TBR-760How we know
- Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With AcromegalyTerminatedPhase 2IpsenNCT00994214Written as BIM 23A760How we know
Codes
What other systems call TBR-760 · ClinicalTrials.gg INT005320
- MeSH (NLM) C531242TBR-760One source NLM
- UNII (FDA) L32IM11DV4ONZIGOLIDEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C531242 | TBR-760 | One source NLM |
| UNII (FDA) | L32IM11DV4 | ONZIGOLIDE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.